Alkylating Agents Flashcards

1
Q

Mechlorethamine (1)

A

Alkylating agent; spontaneous conversion to active metabolites in body fluids or enzymatically converted in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cyclophosphamide (Cytoxan) (1)

A

Alkylating agent; conversion by hepatic cytochrome P450 to active metabolite phosphoramide mustard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ifosfamide (1)

A

Alkylating agent; conversion by hepatic cytochrome P450 to active metabolite phosphoramide mustard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechlorethamine (2)

A

Hodgkin’s disease, topically for treatment of cutaneous T-cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cyclophosphamide (Cytoxan) (2)

A

Most widely used alkylating agent (broad clinical spectrum); singly or in combination for ALL, CLL, non-Hodgkin’s lymphoma, and breast, lung, and ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ifosfamide (2)

A

Sarcoma and testicular cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechlorethamine (3)

A

Severe nausea and vomiting, myelosuppression (leucopenia, thrombocytopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cyclophosphamide (Cytoxan) (3)

A

Hemorrhagic cystitis (bladder irritation) due to acrolein (toxic drug metabolite); adequate hydration and administration of MESNA (2-mercaptoethane sulfonate) minimizes problem. Nausea, vomiting, myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ifosfamide (3)

A

Hemorrhagic cystitis (bladder irritation) due to acrolein (toxic drug metabolite); adequate hydration and administration of MESNA (2-mercaptoethane sulfonate) minimizes problem. Nausea, vomiting, myelosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Carmustine (1)

A

Alkylating agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lomustine (1)

A

Alkylating agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carmustine (2)

A

Brain tumors (cross blood-brain barrier)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lomustine (2)

A

Brain tumors (cross blood-brain barrier)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Carmustine (3)

A

Renal toxicity, pulmonary fibrosis. Profound myelosuppression, severe nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lomustine (3)

A

Renal toxicity, pulmonary fibrosis. Profound myelosuppression, severe nausea and vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Decarbazine (1)

A

Alkylating agent; prodrug activated by liver cytochromes

17
Q

Temozolomide (1)

A

Alkylating agent; nonenzymatic conversion to methylhydrazine at physiologic pH

18
Q

Decarbazine (2)

A

Part of ABVD for Hodgkin’s disease; also, malignant melanoma. IV ADMIN

19
Q

Temozolomide (2)

A

Malignant gliomas ORAL ADMIN

20
Q

Decarbazine (3)

A

Nausea and vomiting, myelosuppression (neutropenia, thrombocytopenia), flu-like symptoms (fever, fatigue)

21
Q

Temozolomide (3)

A

Nausea and vomiting, myelosuppression (neutropenia, thrombocytopenia), flu-like symptoms (fever, fatigue)

22
Q

Cisplatin (1)

A

covalently bind nucleophilic sites on DNA (e.g., guanine N7); converted to active cytotoxic forms by reacting with water to form (+)charged, hydrated intermediates that react with DNA guanine, forming inter- and intrastand cross-links

23
Q

Carboplatin (1)

A

covalently bind nucleophilic sites on DNA (e.g., guanine N7); converted to active cytotoxic forms by reacting with water to form (+)charged, hydrated intermediates that react with DNA guanine, forming inter- and intrastand cross-links

24
Q

Oxaliplatin (1)

A

covalently bind nucleophilic sites on DNA (e.g., guanine N7); converted to active cytotoxic forms by reacting with water to form (+)charged, hydrated intermediates that react with DNA guanine, forming inter- and intrastand cross-links

25
Cisplatin (2)
Testicular, ovarian, cervical, and bladder cancers; also useful in treatment of head and neck cancer, and lung carcinoma
26
Carboplatin (2)
Ovarian cancer
27
Oxaliplatin (2)
Gastric and colorectal cancer
28
Cisplatin (3)
Nephrotoxicity, ototoxicity, peripheral motor and sensory neuropathy at high doses. Myelosupression. Severe nausea and vomiting
29
Carboplatin (3)
Myelosuppression (thrombocytopenia)
30
Oxaliplatin (3)
Peripheral sensory neuropathy (cold-induced). Neutropenia